TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05556044 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05556044 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06045702 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04819178 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05525481 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT05525481 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05833607 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06420973 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05927155 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT05108987 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05299372 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04995523 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06493006 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05268913 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04752904 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05307120 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study NCT05425940 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05019716 — Predictive Biomarker (PRD): BRD4 mRNA
Genes: BRD4; HUNK1
Study NCT05796648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05294991 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05294991 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05625997 — Predictive Biomarker (PRD): IVL mRNA
Genes: IVL
Study NCT03625986 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT03625986 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05472623 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05903118 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06549374 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06222840 — Predictive Biomarker (PRD): SYN1 mRNA
Genes: SYN1
Study NCT04899232 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT05196854 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05196854 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06176937 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05558956 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06194448 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06194448 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04816812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06158204 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04977180 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04699435 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05815303 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05534932 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT06169020 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04976101 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05146570 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05669261 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05582200 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05550493 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05370781 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04808856 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04409873 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05230888 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT04666220 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05242380 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05596890 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04222452 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05807672 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study NCT05179356 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05972967 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT06350929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05346068 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT06375096 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05275504 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05093192 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study NCT06327685 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05907161 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05846737 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT00000986 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05285046 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study NCT04970225 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05828212 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06517004 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06386939 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04979507 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT05453617 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05453617 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT05738850 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05670691 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04706039 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04569721 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05094388 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05094388 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06331195 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT06354790 — Predictive Biomarker (PRD): LAMA2 mRNA
Genes: LAMA2; LAMM
Study NCT06354790 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05559528 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05559528 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06480383 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05933499 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04902846 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06649487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06428292 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06077149 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05739227 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04551521 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04551521 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04551521 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04551521 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04551521 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04551521 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT04551521 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT05214820 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05172739 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05172739 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05278195 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05339672 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study NCT05339672 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05720780 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000896 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00000896 — Safety Biomarker (SAF): Interleukin 12
Study NCT05429294 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05475730 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06189963 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05788185 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04823949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06374017 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05894343 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00002127 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05445791 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05445791 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT05445791 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT05581433 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05697510 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06537908 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06537908 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06064916 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT04625140 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study NCT04931004 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04526769 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT06214702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT05049928 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05391581 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05722665 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04776590 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00000903 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06272045 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06598371 — Predictive Biomarker (PRD): SOCS1 mRNA
Genes: SOCS1; SSI1; TIP3
Study NCT06631846 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06730802 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06730802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05220605 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study NCT05220605 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05220605 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05215912 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05445037 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05961488 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study NCT05272033 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04794569 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT06575686 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT06426134 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT06456996 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05840757 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06265662 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04484025 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04970017 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT04761666 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06436742 — Predictive Biomarker (PRD): DOK7 mRNA
Genes: DOK7; C4orf25
Study NCT05940896 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05273775 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05273775 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT05273775 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05273775 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT05048849 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06469385 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT04923100 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT06254365 — Predictive Biomarker (PRD): LEAP2 mRNA
Genes: LEAP2
Study NCT05296577 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06702579 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05276388 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05692388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05860712 — Surrogate Endpoint (SUR): Bacterial count
Study NCT06661876 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06443567 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05556499 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06329895 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06329895 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06329895 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05302336 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05302336 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05302336 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05302336 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05302336 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05207722 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05207722 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05819931 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04947982 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study NCT06751550 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04490096 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05241093 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05838950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04041232 — Predictive Biomarker (PRD): ATF6 mRNA
Genes: ATF6
Study NCT04305106 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04305106 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04266704 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04697407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04697407 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05730465 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06127979 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT06127979 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05014581 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04208477 — Predictive Biomarker (PRD): BSG mRNA
Genes: BSG; UNQ6505/PRO21383
Study NCT04326569 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT05791604 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06465134 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06221020 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06287099 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06287099 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05457010 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT05359770 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04947995 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04743557 — Predictive Biomarker (PRD): MTM1 mRNA
Genes: MTM1; CG2
Study NCT04743557 — Predictive Biomarker (PRD): DNM2 mRNA
Genes: DNM2; DYN2
Study NCT05626114 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04406129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06300853 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05592587 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05281042 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05559827 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05729282 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05729282 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06251843 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04930692 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT04894526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05134766 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04767529 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT05968222 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05926726 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT05652894 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04763148 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04947163 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03454750 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05762263 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05762263 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05762263 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT06201832 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT04867915 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT06055023 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study NCT06055023 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT06055023 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06055023 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study NCT06385522 — Predictive Biomarker (PRD): TNFRSF1B mRNA
Genes: TNFRSF1B; TNFBR; TNFR2
Study NCT06553235 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06553235 — Safety Biomarker (SAF): Interleukin 1
Study NCT06553235 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06553235 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05330143 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05020626 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05639010 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04895995 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06227104 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06227104 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06227104 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06227104 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT06227104 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05742061 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05742061 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06445114 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06020989 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03466424 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05480384 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06473038 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06576167 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05352581 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05767918 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study NCT05612802 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05611333 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05420259 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05694286 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05132244 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05132244 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06285643 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT06244316 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT06568653 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05008393 — Predictive Biomarker (PRD): STK11 mRNA
Genes: STK11; LKB1; PJS
Study NCT05031637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04948398 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05464355 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU